Nivestym
NDC 0069-0291, filgrastim-aafi, injection, solution, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-0291
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761080
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FILGRASTIM300 ug/.5mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-0291-01 | 00069029101 | 1 SYRINGE in 1 CARTON (0069-0291-01) / .5 mL in 1 SYRINGE |
| 0069-0291-10 | 00069029110 | 10 CARTON in 1 CARTON (0069-0291-10) / 1 SYRINGE in 1 CARTON (0069-0291-01) / .5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d23ab39c-b6ec-41cf-a529-9dd2852c9d9aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0069-0291
Use it
Look up 0069-0291 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-0291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.